【正文】
n JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure[J]. CMAJ, 2022, 175 (6): 611617. [2] Yancy CW, Saltzberg MT, Berkowitz RL, et al. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)[J]. Am J Cardiol, 2022, 94(5): 595601. [3]葉 榕,江 挺,王閩鴻 .腦鈉肽在慢性心力衰竭中的作用 [J].心血管康復(fù)醫(yī)學(xué)雜志, 2022,18(6): 586588. [4] Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of depensated congestive heart failure[J].N Engl J Med, 2022, 343(4): 246253. [5] Yancy CW, Krum H, Massie BM, et second followup serial infusions of nesiritide ( FUSION Ⅱ ) trial for advanced heart failure: study rationale and design [J]. Am Heart J, 2022, 153 (4) : 478484. KKME專(zhuān)業(yè)醫(yī)學(xué)搜索引擎 [6] Zhang J, Fu X, Jia X, et al. Btype natriuretic peptide for prevention of contrastinduced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention[J]. Acta Radiol, 2022, 51(6): 641648. [7] 王日軍,李慧芳,張?jiān)掳?,?.重組人腦利鈉肽治療老年慢性心衰患者急性加重期的臨床療效觀察 [J]. 中國(guó)老年學(xué)雜志,2022,30(5): 11761178. [8] 胡文瑛,汪蔚青,汪志華,等 .不同劑量重組人腦利鈉肽治療心力衰竭的研究 [J]. 現(xiàn)代中西醫(yī)結(jié)合雜志,2022,19(11)13061308. 可以免費(fèi)下載論文的瀏覽器 文獻(xiàn)檢索瀏覽器